Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Organizational Contributors to the Variation in Red Blood Cell Transfusion Practices in Cardiac Surgery: Survey Results From the State of Michigan.
Camaj A, Zahuranec DB, Paone G, Benedetti BR, Behr WD, Zimmerman MA, Zhang M, Kramer RS, Penn J, Theurer PF, Paugh TA, Engoren M, DeLucia A 3rd, Prager RL, Likosky DS; Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative. Camaj A, et al. Anesth Analg. 2017 Sep;125(3):975-980. doi: 10.1213/ANE.0000000000002277. Anesth Analg. 2017. PMID: 28719425 Free PMC article.
Red Blood Cell Transfusions Impact Pneumonia Rates After Coronary Artery Bypass Grafting.
Likosky DS, Paone G, Zhang M, Rogers MA, Harrington SD, Theurer PF, DeLucia A 3rd, Fishstrom A, Camaj A, Prager RL; Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative. Likosky DS, et al. Among authors: camaj a. Ann Thorac Surg. 2015 Sep;100(3):794-800; discussion 801. doi: 10.1016/j.athoracsur.2015.03.089. Epub 2015 Jul 21. Ann Thorac Surg. 2015. PMID: 26209489 Free PMC article.
Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft.
Beerkens FJ, Singh R, Cao D, Claessen BE, Nicolas J, Sartori S, Snyder C, Camaj A, Giustino G, Power D, Razuk V, Jones D, Tavenier AH, Pivato CA, Nardin M, Chiarito M, Krishnan P, Barman N, Baber U, Sweeny J, Dangas G, Sharma SK, Mehran R, Kini A. Beerkens FJ, et al. Among authors: camaj a. Catheter Cardiovasc Interv. 2021 Nov 15;98(6):E785-E795. doi: 10.1002/ccd.29935. Epub 2021 Sep 3. Catheter Cardiovasc Interv. 2021. PMID: 34478235
Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
Guedeney P, Claessen BE, Baber U, Camaj A, Sorrentino S, Aquino M, Blum M, Chandiramani R, Goel R, Elsayed S, Kovacic JC, Sweeny J, Barman N, Moreno P, Dangas GD, Kini A, Sharma S, Mehran R. Guedeney P, et al. Among authors: camaj a. Am J Cardiol. 2019 Jun 1;123(11):1788-1795. doi: 10.1016/j.amjcard.2019.03.005. Epub 2019 Mar 9. Am J Cardiol. 2019. PMID: 30955866
Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention.
Sorrentino S, Baber U, Claessen BE, Camaj A, Vogel B, Sartori S, Guedeney P, Chandrasekhar J, Farhan S, Barman N, Sweeny J, Giustino G, Dangas G, Kini A, Sharma S, Mehran R. Sorrentino S, et al. Among authors: camaj a. Thromb Haemost. 2018 Nov;118(11):1997-2005. doi: 10.1055/s-0038-1673687. Epub 2018 Oct 12. Thromb Haemost. 2018. PMID: 30312975
Temporal trends, determinants, and impact of high-intensity statin prescriptions after percutaneous coronary intervention: Results from a large single-center prospective registry.
Guedeney P, Baber U, Claessen B, Aquino M, Camaj A, Sorrentino S, Vogel B, Farhan S, Faggioni M, Chandrasekhar J, Kalkman DN, Kovacic JC, Sweeny J, Barman N, Moreno P, Vijay P, Shah S, Dangas G, Kini A, Sharma S, Mehran R. Guedeney P, et al. Among authors: camaj a. Am Heart J. 2019 Jan;207:10-18. doi: 10.1016/j.ahj.2018.09.001. Epub 2018 Sep 12. Am Heart J. 2019. PMID: 30404046
Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes.
Schoos M, Power D, Baber U, Sartori S, Claessen B, Camaj A, Steg P, Ariti C, Weisz G, Witzenbichler B, Henry T, Cohen D, Antoniucci D, Krucoff M, Hermiller J, Gibson C, Chieffo A, Moliterno D, Colombo A, Pocock S, Dangas G, Mehran R. Schoos M, et al. Among authors: camaj a. Am J Cardiol. 2019 Mar 1;123(5):709-716. doi: 10.1016/j.amjcard.2018.11.051. Epub 2018 Dec 4. Am J Cardiol. 2019. PMID: 30612724
The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO-3 trial.
Camaj A, Claessen BE, Mehran R, Yudi MB, Power D, Baber U, Hengstenberg C, Lefevre T, Van Belle E, Giustino G, Guedeney P, Sorrentino S, Kupatt C, Webb JG, Hildick-Smith D, Hink HU, Deliargyris EN, Anthopoulos P, Sharma SK, Kini A, Sartori S, Chandrasekhar J, Dangas GD. Camaj A, et al. Catheter Cardiovasc Interv. 2020 Dec;96(7):E688-E694. doi: 10.1002/ccd.28717. Epub 2020 Jan 13. Catheter Cardiovasc Interv. 2020. PMID: 31943717
37 results